As shown by Wang et al., treatment of the diabetic db/db mice with the MIF inhibitor ISO-1 significantly decreased blood glucose levels and albuminuria in these mice, suggesting that MIF inhibition may be a potential therapeutic strategy in diabetic nephropathy (51). The gene discussed is MIF; the disease is diabetic kidney disease.